Ardelyx reported $-37.6M in Net Income for its fiscal quarter ending in March of 2026.





Net Income Change Date
Abbott USD 928M 149M Jun/2026
Amgen USD 1.82B 486M Mar/2026
Ardelyx USD -37.6M 37.2M Mar/2026
aTyr Pharma USD -153K 24.71M Mar/2026
Corcept Therapeutics USD -31.76M 56.05M Mar/2026
Curis USD 19.36M 31.16M Dec/2025
Sanofi EUR 1.61B 2.42B Mar/2026
TG Therapeutics USD 19.78M 3.26M Mar/2026
United Therapeutics USD 274.9M 89.4M Mar/2026